918873-02-6

Basic information

• Product Name: Cyclobutanecarboxylic acid, 1-(4-chlorophenyl)-, methyl ester
• Synonyms: methyl 1-(4-chlorophenyl)cyclobutanecarboxylate;Cyclobutanecarboxylic acid,1-(4-chlorophenyl)-,methyl ester
• CAS NO: 918873-02-6
• Molecular Formula: C12H13ClO2
• Molecular Weight: 224.687
• Mol File: 918873-02-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Cyclobutanecarboxylic acid, 1-(4-chlorophenyl)-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclobutanecarboxylic acid, 1-(4-chlorophenyl)-, methyl ester(918873-02-6)
• EPA Substance Registry System: Cyclobutanecarboxylic acid, 1-(4-chlorophenyl)-, methyl ester(918873-02-6)

Safety Data

• Hazardous Substances Data: 918873-02-6(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 50921-39-6 1-(4-chlorophenyl)cyclobutane-1-carboxylic acid 

Downstream Products

• 635310-39-3 [2-[1-(4-chlorophenyl)cyclobutyl]-2-oxoethyl]phosphonic acid dimethyl ester 

Relevant articles and documents

GAMMA LACTAMS AS PROSTAGLANDIN AGONISTS AND USE THEREOF

1,2-substituted 5-pyrrolidinone compounds are provided, and methods of treatment and pharmaceutical composition that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing preterm labor, dysmenorrhea, asthma, hypertension, infertility or fertility disorder, undesired blood clotting, preeclampsia or eclampsia, an eosinophil disorder, sexual dysfunction, osteporosis and other destructive bone disease or disorder, renal dysfunction, an immune deficiency disorder, dry eye, ichthyosis, elevated intraocular pressure, sleep disorder, or gastric ulcer, inflammatory disorders and other diseases and disorders associated with the prostaglandin family of compounds.